[1] National Center for Cardiovascular Diseases. Annual report on cardiovascular health and diseases in China (2024). Peking Union Medical College Press. 2025. (In Chinese)
[2] Sheng BH, Zhang XY, Yang HX, et al. Change trends and prediction of the burden of cardiovascular and chronic respiratory diseases in Chinese residents from 1990 to 2019. Chin J Public Health, 2024; 40, 477−83. (In Chinese)
[3] National Health Commission of the People’s Republic of China. China health statistics yearbook 2022. Peking Union Medical College Press. 2022. (In Chinese)
[4] Wang W, Liu YN, Liu JM, et al. Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: empirical evidence from national mortality surveillance system. Int J Cardiol, 2021; 340, 105−12. doi:  10.1016/j.ijcard.2021.08.034
[5] Diao FC. After nearly 20 years of tobacco control, when will the inflection point of declining tobacco production and sales in China arrive?. https://m.thepaper.cn/newsDetail_forward_28541881. [2024-08-30]. (In Chinese)
[6] Chinese Center for Disease Control and Prevention. Data chart of smoking rates among people aged 15 and above in various regions in 2020. https://www.chinacdc.cn/jksj/jksj04/202407/t20240731_287942.html. [2024-08-30]. (In Chinese)
[7] Zeng XY, Liu SW, Xiao L. Cigarette use and secondhand smoke exposure among secondary school students—China, 2023. China CDC Wkly, 2024; 6, 509−15. doi:  10.46234/ccdcw2024.098
[8] National Disease Control and Prevention Administration. Report on Chinese residents’ chronic diseases and nutrition 2020. People's Medical Publishing House. 2022. (In Chinese)
[9] Zhao LY, Ding GQ, Zhao WH. Report on nutrition and health surveillance of Chinese residents 2015 - 2017. People's Medical Publishing House. 2022. (In Chinese)
[10] Yuan XR, Wei YL, Jiang HR, et al. Longitudinal relationship between the percentage of energy intake from macronutrients and overweight/obesity among Chinese adults from 1991 to 2018. Nutrients, 2024; 16, 666. doi:  10.3390/nu16050666
[11] Jia XF, Su C, He YN, et al. Macronutrient intake status and food sources in adult residents from 10 provinces (autonomous regions) of China in 2022-2023. J Hyg Res, 2024; 53, 862−9. (In Chinese)
[12] Zhao WH, Li SJ, Yang ZY, et al. Nutrition and health atlas of Chinese children. SinoMaps Press. 2024. (In Chinese)
[13] Wang H, Zhang YF, Wu DM, et al. Spatial distribution and related factors of physical activity, screen time and sleep time compliance rates of Chinese children from 3 to 6 years old. China Sport Sci, 2023; 43, 26−33. (In Chinese)
[14] Chen PJ. Report on physical activity and fitness in China, the youth study 2016. Science Press. 2016. (In Chinese)
[15] Fan X, Cao ZB. Physical activity among Chinese school-aged children: national prevalence estimates from the 2016 physical activity and fitness in China-the Youth Study. J Sport Health Sci, 2017; 6, 388−94. doi:  10.1016/j.jshs.2017.09.006
[16] Zhu Z, Tang Y, Zhuang J, et al. Physical activity, screen viewing time, and overweight/obesity among Chinese children and adolescents: an update from the 2017 physical activity and fitness in China-the youth study. BMC Public Health, 2019; 19, 197. doi:  10.1186/s12889-019-6515-9
[17] Guo MM, Koh KT, Wang XZ. Trends of physical activity and recreational screen time among Chinese children and adolescents: a national study from 2017 to 2019. BMC Public Health, 2024; 24, 1305. doi:  10.1186/s12889-024-18822-1
[18] Xin F, Zhu Z, Chen ST, et al. Prevalence and correlates of meeting the muscle-strengthening exercise recommendations among Chinese children and adolescents: results from 2019 Physical Activity and Fitness in China-The Youth Study. J Sport Health Sci, 2022; 11, 358−66. doi:  10.1016/j.jshs.2021.09.010
[19] Song Y, Luo DM, Hu PJ, et al. Trends of prevalence of excellent health status and physical fitness among Chinese Han students aged 13 to 18 years from 1985 to 2014. J Peking Univ (Health Sci), 2020; 52, 317−22. (In Chinese)
[20] Dong YH, Chen L, Liu JY, et al. Epidemiology and prediction of overweight and obesity among children and adolescents aged 7-18 years in China from 1985 to 2019. Chin J Prev Med, 2023; 57, 461−9. (In Chinese)
[21] Wang LM, Zhou B, Zhao ZP, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18. Lancet, 2021; 398, 53−63. doi:  10.1016/S0140-6736(21)00798-4
[22] Luo YM, Xia F, Yu XX, et al. Long-term trends and regional variations of hypertension incidence in China: a prospective cohort study from the China Health and Nutrition Survey, 1991-2015. BMJ Open, 2021; 11, e042053. doi:  10.1136/bmjopen-2020-042053
[23] Zhang M, Wu J, Zhang X, et al. Prevalence and control of hypertension in adults in China, 2018. Chin J Epidemiol, 2021; 42, 1780−9. (In Chinese)
[24] Zhao WH, Zhang J, You Y, et al. Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China. Chin J Prev Med, 2005; 39, 306−10. (In Chinese)
[25] Pan L, Yang ZH, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis, 2016; 248, 2−9. doi:  10.1016/j.atherosclerosis.2016.02.006
[26] Dai J, Min JQ, Yang YJ. A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China. Chin J Cardiol, 2018; 46, 114−8. (In Chinese)
[27] National Disease Control and Prevention Administration. Report on Chinese residents’ chronic diseases and nutrition 2015. People's Medical Publishing House. 2015. (In Chinese)
[28] Li SN, Zhang LF, Wang X, et al. Status of dyslipidemia among adults aged 35 years and above in China. Chin Circ J, 2019; 34, 681−7. (In Chinese)
[29] Lu Y, Zhang HB, Lu JP, et al. Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China. JAMA Netw Open, 2021; 4, e2127573. doi:  10.1001/jamanetworkopen.2021.27573
[30] Wang LM, Peng W, Zhao ZP, et al. Prevalence and treatment of diabetes in China, 2013-2018. JAMA, 2021; 326, 2498−506. doi:  10.1001/jama.2021.22208
[31] Yang C, Wang HB, Zhao XJ, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis, 2020; 76, 258−64. doi:  10.1053/j.ajkd.2019.05.032
[32] Zhang LX, Zhao MH, Zuo L, et al. China kidney disease network (CK-NET) 2016 annual data report. Kidney Int Suppl (2011), 2020; 10, e97−185. doi:  10.1016/j.kisu.2020.09.001
[33] Wang LM, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the Sixth China chronic disease and risk factor surveillance. JAMA Intern Med, 2023; 183, 298−310. doi:  10.1001/jamainternmed.2022.6817
[34] Zhang LX, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet, 2012; 379, 815−22. doi:  10.1016/S0140-6736(12)60033-6
[35] Chen P, Lam MI, Si TL, et al. The prevalence of poor sleep quality in the general population in China: a meta-analysis of epidemiological studies. Eur Arch Psychiatry Clin Neurosci, 2024; 274, 1−14.
[36] Wang DF, Li HL, Zhang XT, et al. Changes and relevant factors in depressive and anxiety symptoms among Chinese adolescents after the “Double Reduction” policy: a repeated cross-sectional survey with a nested longitudinal subsample. J Affec Disord, 2024; 367, 88−95. doi:  10.1016/j.jad.2024.08.191
[37] Liang FC, Xiao QY, Huang KY, et al. The 17-y spatiotemporal trend of PM2.5 and its mortality burden in China. Proc Natl Acad Sci USA, 2020; 117, 25601−8. doi:  10.1073/pnas.1919641117
[38] Ma GS, Meyer CL, Jackson-Morris A, et al. The return on investment for the prevention and treatment of childhood and adolescent overweight and obesity in China: a modelling study. Lancet Reg Health West Pac, 2023; 43, 100977.
[39] Li JT, Zhao D, Cai J, et al. Cost-effectiveness of treatment in adults with blood pressure of 130-139/80-89 mmHg and high cardiovascular risk in China: a modelling study. Lancet Reg Health West Pac, 2024; 42, 100962.